News
-
-
COMMUNIQUÉ DE PRESSE
Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy
Laxxon Medical to showcase cGMP Printing Technology at CPHI Milan 2024, unveiling innovative oral drug delivery systems through SPID® Technology -
-
-
COMMUNIQUÉ DE PRESSE
Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US
Laxxon Medical & Adare Pharma Cooperate for cGMP 3D Printed Oral Dosage Forms production in Europe & US. Utilizing SPID® Technology by Laxxon & Adare's cGMP-certified facilities -
-
-
COMMUNIQUÉ DE PRESSE
Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market
Laxxon Medical announces development program for LXM.2, a 3D printed oral GLP-1 receptor agonist for obesity treatment, offering an alternative to injections. Utilizes SPID® platform technology for enhanced bioavailability -
-
